Semnur Pharmaceuticals, Inc. Current Assets
Semnur Pharmaceuticals, Inc. (SMNR) had Current Assets of $1.19 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-10
- 2026-06-30: Assets, Current $1.19M.
- 2026-03-31: Assets, Current $1.22M.
- 2025-12-31: Assets, Current $596.00K.
- 2025-09-30: Assets, Current $85.00K.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.19M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.22M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $596.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $85.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $14.14K 10-Q · filed 2025-08-15 | |
| 2025-03-31 | $2.74K 10-Q · filed 2025-05-16 | |
| 2024-12-31 | $6.00M S-1 · filed 2026-05-12 | $16.87K 10-K · filed 2025-04-02 |
| 2024-09-30 | $35.43K 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $43.78K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $65.41K 10-Q · filed 2024-05-22 | |
| 2023-12-31 | $209.44K 10-K · filed 2025-04-02 | |
| 2023-09-30 | $35.65K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $54.45K 10-Q · filed 2023-08-15 | |
| 2023-03-31 | $673.26K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $907.84K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $1.12M 10-Q · filed 2022-11-16 | |
| 2022-06-30 | $1.26M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $16.57K 10-Q · filed 2022-05-23 |